HRT Financial’s GeoVax Labs GOVX Stock Holding History

HRT Financial’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Buy	+126,704	New	+$193K	﹤0.01%	3471
2026 Q1	–	Sell	-7,409	Closed	-$31K	–	4147
2025 Q4	$31K	Buy	+7,409	New	+$81.5K	﹤0.01%	2937
2022 Q4	–	Sell	-31	Closed	-$12K	–	2715
2022 Q3	$12K	Buy	+31	New	+$17.9K	﹤0.01%	2523

Other funds holding GOVX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's GOVX Position: Q2 2026 in Review

HRT Financial opened a new position in GeoVax Labs (GOVX) in Q2 2026: 126,704 shares worth $160K. The stake represents ﹤0.01% of the portfolio and ranks #3471 among its holdings. This is a return to the name: HRT Financial previously reported a position in GOVX as recently as Q4 2025.

HRT Financial first reported a position in GOVX in Q3 2022 and has held it in 3 quarters since. 17 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

HRT Financial held 126,704 shares of GeoVax Labs worth $160K as of Q2 2026.
GeoVax Labs was a new HRT Financial position in Q2 2026.
GeoVax Labs made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3471 holding.
HRT Financial first reported a position in GeoVax Labs in Q3 2022 and has held it in 3 quarters since.
17 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.